193 related articles for article (PubMed ID: 36059163)
1. HSPA5 is a prognostic biomarker correlated with immune infiltrates in thyroid carcinoma.
Dong W; Du D; Huang H
Endokrynol Pol; 2022; 73(4):680-689. PubMed ID: 36059163
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of BTNL9 as a prognostic biomarker correlated with immune infiltrations in thyroid cancer.
Zhang L; Yu S; Hong S; Xiao X; Liao Z; Li Y; Xiao H
BMC Med Genomics; 2023 Oct; 16(1):234. PubMed ID: 37798795
[TBL] [Abstract][Full Text] [Related]
3. DNAJB11 predicts a poor prognosis and is associated with immune infiltration in thyroid carcinoma: a bioinformatics analysis.
Sun R; Yang L; Wang Y; Zhang Y; Ke J; Zhao D
J Int Med Res; 2021 Nov; 49(11):3000605211053722. PubMed ID: 34727750
[TBL] [Abstract][Full Text] [Related]
4. Key molecules associated with thyroid carcinoma prognosis: A study based on transcriptome sequencing and GEO datasets.
Bai M; Ke S; Yu H; Xu Y; Yu Y; Lu S; Wang C; Huang J; Ma Y; Dai W; Wu Y
Front Immunol; 2022; 13():964891. PubMed ID: 36059514
[TBL] [Abstract][Full Text] [Related]
5. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T
BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405
[TBL] [Abstract][Full Text] [Related]
6. Construction of a ferroptosis-related five-lncRNA signature for predicting prognosis and immune response in thyroid carcinoma.
Qin Y; Zhang D; Zhang H; Hou L; Wang Z; Yang L; Zhang M; Zhao G; Yao Q; Ling R; Zhang J
Cancer Cell Int; 2022 Sep; 22(1):296. PubMed ID: 36175889
[TBL] [Abstract][Full Text] [Related]
7. Bioinformatics analysis for the identification of Sprouty-related EVH1 domain-containing protein 3 expression and its clinical significance in thyroid carcinoma.
Zhang X; Meng X; Wang P; Luan C; Wang H
Sci Rep; 2024 Feb; 14(1):4549. PubMed ID: 38402263
[TBL] [Abstract][Full Text] [Related]
8. Estrogen-related genes for thyroid cancer prognosis, immune infiltration, staging, and drug sensitivity.
Zhang L; Zhou M; Gao X; Xie Y; Xiao J; Liu T; Zeng X
BMC Cancer; 2023 Oct; 23(1):1048. PubMed ID: 37907864
[TBL] [Abstract][Full Text] [Related]
9. A pan-cancer analysis to determine the prognostic analysis and immune infiltration of HSPA5.
Zhu RK; Zhang W; Zhang YX; Hui Z; Wang XW
Curr Cancer Drug Targets; 2023 May; ():. PubMed ID: 37157205
[TBL] [Abstract][Full Text] [Related]
10. NKD2 is correlated with the occurrence, progression and prognosis of thyroid carcinoma.
Gao Y; Wang Y; Guo R
Eur J Med Res; 2022 Nov; 27(1):235. PubMed ID: 36348408
[TBL] [Abstract][Full Text] [Related]
11. A Pan-Cancer Analysis of the Oncogenic Role of
Yang D; Li H; Chen Y; Li C; Ren W; Huang Y
Front Genet; 2022; 13():906174. PubMed ID: 35910232
[No Abstract] [Full Text] [Related]
12. Chemokine CCL14 affected the clinical outcome and correlated with immune infiltrates in thyroid carcinoma.
Zhang MM; Zhao YD; Li Q; He YJ
Histol Histopathol; 2023 Jun; 38(6):695-707. PubMed ID: 36409028
[TBL] [Abstract][Full Text] [Related]
13. High expression of
Luo X; Chen X; Chen S; Gao Q; Yang H; Zhao D
Gland Surg; 2022 Feb; 11(2):412-425. PubMed ID: 35284305
[TBL] [Abstract][Full Text] [Related]
14. Identification and validation of a glycolysis-related gene signature for predicting metastasis and survival rate in patients with thyroid cancer.
Wang B; Zhu Y; Zhang X; Wang Z
Transl Cancer Res; 2023 May; 12(5):1100-1111. PubMed ID: 37304543
[TBL] [Abstract][Full Text] [Related]
15. Mining Prognostic Biomarkers of Thyroid Cancer Patients Based on the Immune-Related Genes and Development of a Reliable Prognostic Risk Model.
Fei H; Han X; Wang Y; Li S
Mediators Inflamm; 2023; 2023():6503476. PubMed ID: 37554551
[TBL] [Abstract][Full Text] [Related]
16. LncRNA ALMS1-IT1 is a novel prognostic biomarker and correlated with immune infiltrates in colon adenocarcinoma.
Lin Y; Li Y; Chen Y; Zhang Z
Medicine (Baltimore); 2022 Oct; 101(42):e31314. PubMed ID: 36281164
[TBL] [Abstract][Full Text] [Related]
17. Systematic analysis of the prognosis and immune infiltration of E2Fs in thyroid carcinoma.
Fu X; Zhou X; Ji F; He Q; Qiu X
Front Genet; 2023; 14():1215984. PubMed ID: 37560385
[No Abstract] [Full Text] [Related]
18. NDUFA4L2 is a novel biomarker for colorectal cancer through bioinformatics analysis.
Lin Y; Xie H; Zhao W; Li Y; Zhang Z
Medicine (Baltimore); 2023 Nov; 102(44):e35893. PubMed ID: 37933010
[TBL] [Abstract][Full Text] [Related]
19. Increased SEMA6B expression as a potential prognostic and immune cell infiltration biomarker in thyroid cancer patients.
Lei Q; Wang Y; Li J; Wang S; Hu Y; Duan L; Huo Y; Wu Y; Liu H
Aging (Albany NY); 2023 May; 15(9):3572-3585. PubMed ID: 37155149
[TBL] [Abstract][Full Text] [Related]
20. Elevated PDE4C level serves as a candidate diagnostic biomarker and correlates with poor survival in thyroid carcinoma.
Wang Y; Zhang Y; Li Y; Huang J
Sci Rep; 2024 Mar; 14(1):6813. PubMed ID: 38514754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]